Literature DB >> 3260443

Psychosomatic aspects of coronary artery bypass graft surgery. A prospective study of 101 male patients.

J Eriksson1.   

Abstract

101 consecutive male patients were examined by means of clinical interviews and depression, anxiety, personality, psychometric and life stress tests. The examinations took place preoperatively, on the 9th postoperative day (average) and 7.5 months after surgery. The mean age of the patients was 52.2 years and the mean duration of CHD was 6.7 years. Prior to surgery 77% had experienced myocardial infarction and 85% belonged to NYHA class III or IV. 74% had a 3-vessel disease. When the NYHA classification was used as criterion for rehabilitation the result was excellent. Postoperatively 80% belonged to NYHA class I or II. Hospital mortality rate was 4% and one patient died from myocardial infarction prior to the final follow-up. Preoperatively 17% of the study group were working. 87% of the patients experienced negative effects on work life, caused by CHD. Postoperatively 33% worked regularly. The postoperative work situation correlated with the duration of preoperative unemployment (p less than 0.0001), the patient's own opinion about work return (willingness/unwillingness to return to work) (p less than 0.01), as well as with the amount of negative life stress experienced preoperatively (p less than 0.01). Only 13% of the series experienced positive effects on work life, caused by CABG surgery. The majority of the patients had experienced negative effects on social and economic life (51%), as well as on sexual life (70%), caused by CHD. After surgery improvements were noted by 36% on social life and by 27% on sexual life. 15% experienced impairment of sexual life postoperatively. According to the Beck Depression Inventory 29% showed depression preoperatively, and 10% postoperatively. The difference is significant (p less than 0.0001). Clinically the figures tended to be higher. The same tendency holds for anxiety scores as measured by the Hamilton anxiety scale. The incidence of postoperative psychoses was 35%. Higher age (p less than 0.01) and/or absence of psychosomatic diseases (p less than 0.05) correlated with higher frequency of psychoses. Even though cardiological rehabilitation according to the NYHA classification was excellent, 22% of the series did not think their expectations were fulfilled. Psychic and social rehabilitation was in several aspects unsatisfactory, and the patients did not seem prepared for this. The importance to consider rehabilitation from a psychosomatic standpoint is clearly shown. To predict the result of rehabilitation preoperatively is not possible.

Entities:  

Mesh:

Year:  1988        PMID: 3260443     DOI: 10.1111/j.1600-0447.1988.tb10568.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  5 in total

1.  Quality of life during rehabilitation after coronary artery bypass surgery.

Authors:  E Engblom; H Hämäläinen; J Lind; C E Mattlar; S Ollila; V Kallio; M Inberg; L R Knuts
Journal:  Qual Life Res       Date:  1992-06       Impact factor: 4.147

Review 2.  A critical review of dimension-specific measures of health-related quality of life in cross-cultural research.

Authors:  M J Naughton; I Wiklund
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

Review 3.  Psychiatric complications in the critically ill cardiac patient.

Authors:  K M Sanders; E H Cassem
Journal:  Tex Heart Inst J       Date:  1993

4.  Emotional processes in patients undergoing coronary artery bypass graft surgeries with extracorporeal circulation in view of selected indicators of the inflammatory condition.

Authors:  Włodzimierz Płotek; Joanna Pielok; Marcin Cybulski; Regina Samborska
Journal:  Med Sci Monit       Date:  2015-01-09

5.  Impact of Experiencing Acute Coronary Syndrome Prior to Open Heart Surgery on Psychiatric Status.

Authors:  Volkan Yüksel; Yasemin Gorgulu; Rugul Kose Cinar; Serhat Huseyin; Mehmet Bulent Sonmez; Suat Canbaz
Journal:  Braz J Cardiovasc Surg       Date:  2016 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.